During the past decade a number of investigators have attempted to develop mouse models of diabetic macrovascular disease. Hyperglycemia might increase vascular damage because it increases oxidant stress. For this reason we studied animals that were deficient in HDL; HDL is widely believed to protect against oxidant stress. An inbred line of mice doubly deficient in LDL receptor and apoAI was made diabetic with streptozotocin (STZ); control mice had an average glucose of 7.2+/-2mmol/l and STZ-treated mice had an average glucose of 19.4+/-6.5mmol/l. The animals were fed a high cholesterol but low fat diet leading to plasma cholesterol levels of 9.4+/-1.6mmol/l in control animals and 10.1+/-1.8mmol/l in STZ-treated mice. The control and STZ-treated animals had similar plasma lipoprotein profiles. Atherosclerosis assessed at 23 weeks averaged 38154microm(2) in control and 32962microm(2) in STZ-treated mice. Therefore STZ-induced diabetes does not alter plasma lipoproteins or atherosclerosis in HDL deficient mice.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.atherosclerosis.2003.09.014 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Genetic deletion of calcium-independent phospholipase A2γ protects mice from diabetic nephropathy.
PLoS One
October 2024
Department of Medicine, McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
Article Synopsis
- Calcium-independent phospholipase A2γ (iPLA2γ) plays a role in kidney health, with its deletion in mice leading to mitochondrial issues and heightened autophagy in kidney cells, yet not causing albuminuria directly.
- In a study involving diabetic models, iPLA2γ knockout (KO) mice did not show the expected increase in albuminuria compared to control mice, even with similar hyperglycemia levels.
- The findings suggest that the absence of iPLA2γ offers protection against chronic kidney damage during diabetes, linked to enhanced autophagy in the glomeruli.
SREBP1 induction mediates long-term statins therapy related myocardial lipid peroxidation and lipid deposition in TIIDM mice.
Redox Biol
December 2024
Guangdong Engineering & Technology Research Center for Disease-Model Animals, Laboratory Animal Center, Guangzhou, 510080, Guangdong, PR China; Department of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, Guangdong, PR China. Electronic address:
Statins therapy is efficacious in diminishing the risk of major cardiovascular events in diabetic patients. However, our research has uncovered a correlation between the prolonged administration of statins and an elevated risk of myocardial dysfunction in patients with type II diabetes mellitus (TIIDM). Here, we report the induction of sterol regulatory element-binding protein 1 (SREBP1) activation, associated lipid peroxidation, and the consequent diabetic myocardial dysfunction after statin treatment and explored the underlying mechanisms.
View Article and Find Full Text PDFAlpha- to Beta-Cell Transdifferentiation in Neonatal Compared with Adult Mouse Pancreas in Response to a Modest Reduction in Beta-Cells Using Streptozotocin.
Int J Mol Sci
October 2024
Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 3K7, Canada.
Following the near-total depletion of pancreatic beta-cells with streptozotocin (STZ), a partial recovery of beta-cell mass (BCM) can occur, in part due to the alpha- to beta-cell transdifferentiation with an intermediary insulin/glucagon bi-hormonal cell phenotype. However, human type 2 diabetes typically involves only a partial reduction in BCM and it is not known if recovery after therapeutic intervention involves islet cell transdifferentiation, or how this varies with age. Here, we used transgenic mouse models to examine if islet cell transdifferentiation contributes to BCM recovery following only a partial depletion of BCM.
View Article and Find Full Text PDFDiabetic Mice Spleen Vulnerability Contributes to Decreased Persistence of Antibody Production after SARS-CoV-2 Vaccine.
Int J Mol Sci
September 2024
Department of Physiology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Article Synopsis
- During the COVID-19 pandemic, patients with diabetes and obesity faced more severe health outcomes and lower vaccination efficacy compared to those without these conditions.
- Our study explored how diabetes affects immune responses to the SARS-CoV-2 vaccine using diabetic mouse models, revealing lower antibody levels in both types of diabetic mice compared to healthy mice.
- Despite these immune deficiencies, vaccination did not worsen diabetes-related complications, indicating the safety of the vaccine for diabetic individuals and highlighting mechanisms that might explain reduced antibody production in these patients.*
Cardioprotective effects of polydatin against myocardial injury in HFD/stz and high glucose-induced diabetes via a Caveolin 1-dependent mechanism.
Phytomedicine
December 2024
Department of Clinical Medicine, Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, 310000, PR China. Electronic address:
Article Synopsis
- Diabetic cardiomyopathy (DCM) is a type of heart dysfunction that occurs without coronary artery disease and can lead to heart failure, with limited treatments available.
- Polydatin (PD), derived from traditional herbs, shows promise in improving the condition, although its exact cardioprotective mechanisms, particularly regarding a protein called Cav1, are not fully understood.
- The study found that PD significantly improved heart function in diabetic mice, but its benefits were lost when Cav1 was absent, suggesting that Cav1 plays a crucial role in PD's ability to protect the heart from diabetes-related damage.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!